The immune response in NSCLC is often mediated by the PD-1/PD-L1 regulatory axis, where the interaction of PD-1 on effector T cells with PD-L1 expressed by tumor cells acts as an inhibitory signal [38]. This evidence concerns the gene CD274 and neoplasm.